title: Elucidating molecular mass and shape of a neurotoxic Aβ oligomer.
abstract: Alzheimer's disease (AD), the most prevalent type of dementia, has been associated with the accumulation of amyloid β oligomers (AβOs) in the central nervous system. AβOs vary widely in size, ranging from dimers to larger than 100 kDa. Evidence indicates that not all oligomers are toxic, and there is yet no consensus on the size of the actual toxic oligomer. Here we used NU4, a conformation-dependent anti-AβO monoclonal antibody, to investigate size and shape of a toxic AβO assembly. By using size-exclusion chromatography and immuno-based detection, we isolated an AβO-NU4 complex amenable for biochemical and morphological studies. The apparent molecular mass of the NU4-targeted oligomer was 80 kDa. Atomic force microscopy imaging of the AβO-NU4 complex showed a size distribution centered at 5.37 nm, an increment of 1.5 nm compared to the size of AβOs (3.85 nm). This increment was compatible with the size of NU4 (1.3 nm), suggesting a 1:1 oligomer to NU4 ratio. NU4-reactive oligomers extracted from AD human brain concentrated in a molecular mass range similar to that found for in vitro prepared oligomers, supporting the relevance of the species herein studied. These results represent an important step toward understanding the connection between AβO size and toxicity.
authors.affiliation: Department of Neurobiology, Northwestern University , Evanston, Illinois 60208, United States.
authors.forename: Adriano
authors.initials: A
authors.lastname: Sebollela
authors.forename: Gina-Mirela
authors.initials: GM
authors.lastname: Mustata
authors.forename: Kevin
authors.initials: K
authors.lastname: Luo
authors.forename: Pauline T
authors.initials: PT
authors.lastname: Velasco
authors.forename: Kirsten L
authors.initials: KL
authors.lastname: Viola
authors.forename: Erika N
authors.initials: EN
authors.lastname: Cline
authors.forename: Gajendra S
authors.initials: GS
authors.lastname: Shekhawat
authors.forename: Kyle C
authors.initials: KC
authors.lastname: Wilcox
authors.forename: Vinayak P
authors.initials: VP
authors.lastname: Dravid
authors.forename: William L
authors.initials: WL
authors.lastname: Klein
mesh_terms: D000544:Alzheimer Disease / Q000473:pathology*; D016229:Amyloid beta-Peptides / Q000276:immunology* / Q000633:toxicity*; D000818:Animals; D000906:Antibodies / Q000633:toxicity*; D001921:Brain / Q000378:metabolism*; D002478:Cells, Cultured; D002850:Chromatography, Gel; D004622:Embryo, Mammalian; D005260:Female; D006624:Hippocampus / Q000166:cytology; D006801:Humans; D000922:Immunotoxins / Q000633:toxicity; D018625:Microscopy, Atomic Force; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism; D011247:Pregnancy; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D016229:Amyloid beta-Peptides; D000906:Antibodies; D000922:Immunotoxins
keywords: AFM; Alzheimer’s disease; Aβ oligomer; NU4 antibody; neurotoxicity